Werewolf Therapeutics (HOWL) Long-Term Debt Issuances (2023 - 2024)
Werewolf Therapeutics (HOWL) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $30.0 million as the latest value for Q2 2024.
- On a quarterly basis, Long-Term Debt Issuances changed N/A to $30.0 million in Q2 2024 year-over-year; TTM through Sep 2025 was $30.0 million, a 0.0% change, with the full-year FY2024 number at $30.0 million, down 25.0% from a year prior.
- Long-Term Debt Issuances was $30.0 million for Q2 2024 at Werewolf Therapeutics, down from $40.0 million in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $40.0 million in Q1 2023 to a low of $30.0 million in Q2 2024.